Duane Mitchell

A new discovery led by Dr. Catherine Flores using stem cells to overcome resistance to immunotherapy drugs may open the door to more effective treatment for brain cancer.

In The Conversation, Dr. Duane Mitchell discusses the importance of Drs. James Allison and Tasuku Honjo's discoveries in immunotherapy.

Duane Mitchell, M.D., Ph.D., co-director of the Preston A. Wells, Jr. Center for Brain Tumor Therapy, announced the UF Health-led Legacy Program in Brain Cancer at the Biden Cancer Summit.

Brain cancer experts at the MBI launch a new venture with institutions from across the nation and Canada.

Watch Dr. Duane Mitchell's talk at the Biden Cancer Summit live — and tune into talks from other UF Brain Tumor Immunotherapy Program team members leading up to it.

On Saturday, Aug. 25, Sen. John McCain lost his courageous year-plus battle with glioblastoma. Dr. Duane Mitchell discusses the disease and his hope for future research breakthroughs.

Brian Hoh, M.D., an internationally known expert in the treatment of brain aneurysms, brain arteriovenous malformations, and ischemic and hemorrhagic stroke, will lead the department of neurosurgery.

UF Brain Tumor Education Day will offer patients with brain tumors and caregivers the opportunity to learn about treatment options and resources available at UF Health.

A strong showing by the Brain Tumor Immunotherapy Program team at this year's Society for Neuro-Oncology meeting included a Top 5 Poster Award for Drs. Loic Deleyrolle and Lan Hoang-Minh.

Duane Mitchell, M.D., Ph.D., co-director of UF’s Preston A. Wells Jr. Center for Brain Tumor Therapy and head of the Cancer Therapeutics & Immuno-Oncology program at the UF Health Cancer Center, presented a conversation about the use of immunotherapy to treat brain cancers on Monday, Feb. 13 at 6 p.m.